Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lipocine Inc (NQ: LPCN )

0.4567 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4567
Bid (Size) 0.4000 (10)
Ask (Size) 0.5000 (2)
Prev. Close 0.4567
Today's Range 0.4567 - 0.4567
52wk Range 0.3600 - 1.890
Shares Outstanding 88,510,791
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers 
Via Benzinga

Performance

YTD
-58.10%
-58.10%
1 Month
+11.66%
+11.66%
3 Month
-24.71%
-24.71%
6 Month
-43.69%
-43.69%
1 Year
-58.48%
-58.48%

More News

Read More
Lipocine To Focus On Central Nervous System Conditions; Explores Partnerships For Non-Core Assets
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Lipocine Posts Encouraging Data For Testosterone Prodrug In NASH Patients
Via Benzinga
Antares Pharma's Oral Testosterone Treatment Scores FDA Approval
Via Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Recap: Lipocine Q2 Earnings
Via Benzinga
Lipocine Gets FDA Nod For Mid-Stage Epilepsy Study
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
4 Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
7 Undervalued Penny Stocks With Major Upside
Via InvestorPlace
36 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Via Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.